Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders

被引:0
|
作者
Wolfgang Jordan
Henrik Dobrowolny
Sabine Bahn
Hans-Gert Bernstein
Tanja Brigadski
Thomas Frodl
Berend Isermann
Volkmar Lessmann
Jürgen Pilz
Andrea Rodenbeck
Kolja Schiltz
Edzard Schwedhelm
Hayrettin Tumani
Jens Wiltfang
Paul C. Guest
Johann Steiner
机构
[1] Magdeburg Hospital GmbH,Department of Psychiatry and Psychotherapy
[2] University of Goettingen,Department of Psychiatry and Psychotherapy
[3] University of Magdeburg,Department of Psychiatry and Psychotherapy
[4] University of Cambridge,Department of Chemical Engineering and Biotechnology
[5] University of Magdeburg,Institute of Physiology
[6] Center for Behavioral Brain Sciences,Institute of Clinical Chemistry and Pathobiochemistry
[7] University of Magdeburg,Sleep Laboratory, Department of Pneumology
[8] Laboratory of Stress Monitoring,Department of Sleep Medicine and Clinical Chronobiology, Institute of Physiology, St. Hedwig Hospital, Charite
[9] Evangelisches Krankenhaus Goettingen-Weende gGmbH,Institute of Experimental and Clinical Pharmacology and Toxicology
[10] University of Berlin,Department of Neurology
[11] University Medical Center Hamburg-Eppendorf,Department of Biochemistry and Tissue Biology
[12] University of Ulm,undefined
[13] Fachklinik für Neurologie Dietenbronn,undefined
[14] German Center for Neurodegenerative Diseases (DZNE),undefined
[15] University of Campinas (UNICAMP),undefined
来源
European Archives of Psychiatry and Clinical Neuroscience | 2018年 / 268卷
关键词
Oxidative stress; Schizophrenia; Depression; 8-Iso-prostaglandin F2α; Isoprostane; Malondialdehyde; 8-OH-2-deoyxguanosine; Superoxide dismutase; Glutathione ; -transferase;
D O I
暂无
中图分类号
学科分类号
摘要
Oxidative stress and immune dysregulation have been linked to schizophrenia and depression. However, it is unknown whether these factors are related to the pathophysiology or whether they are an epiphenomenon. Inconsistent oxidative stress-related findings in previous studies may have resulted from the use of different biomarkers which show disparate aspects of oxidative stress. Additionally, disease severity, medication, smoking, endocrine stress axis activation and obesity are potential confounders. In order to address some of these shortcomings, we have analyzed a broader set of oxidative stress biomarkers in our exploratory study, including urinary 8-iso-prostaglandin F2α (8-iso-PGF2α), 8-OH-2-deoyxguanosine (8-OH-2-dG), and blood levels of malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione S-transferase (GST) in acutely ill drug-naïve first episode patients with schizophrenia (n = 22), major depression (n = 18), and controls (n = 43). Possible confounding factors were considered, and patients were followed-up after 6 weeks of treatment. No differences were observed regarding 8-OH-2-dG, MDA and GST. At baseline, 8-iso-PGF2α levels were higher in patients with schizophrenia (p = 0.004) and major depression (p = 0.037), with a trend toward higher SOD concentrations in schizophrenia (p = 0.053). After treatment, schizophrenia patients showed a further increase in 8-iso-PGF2α (p = 0.016). These results were not related to age, sex, disease severity, medication or adipose tissue mass. However, 8-iso-PGF2α was associated with smoking, endocrine stress axis activation, C-reactive protein levels and low plasma concentrations of brain-derived neurotrophic factor. This study suggests a role of lipid peroxidation particularly in drug-naïve acutely ill schizophrenia patients and highlights the importance of taking into account other confounding factors in biomarker studies.
引用
收藏
页码:129 / 143
页数:14
相关论文
共 50 条
  • [1] Oxidative stress in drug-na⟨ve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders
    Jordan, Wolfgang
    Dobrowolny, Henrik
    Bahn, Sabine
    Bernstein, Hans-Gert
    Brigadski, Tanja
    Frodl, Thomas
    Isermann, Berend
    Lessmann, Volkmar
    Pilz, Juergen
    Rodenbeck, Andrea
    Schiltz, Kolja
    Schwedhelm, Edzard
    Tumani, Hayrettin
    Wiltfang, Jens
    Guest, Paul C.
    Steiner, Johann
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2018, 268 (02) : 129 - 143
  • [2] Glucose homeostasis in major depression and schizophrenia: a comparison among drug-naïve first-episode patients
    Johann Steiner
    Brisa S. Fernandes
    Paul C. Guest
    Henrik Dobrowolny
    Gabriela Meyer-Lotz
    Sabine Westphal
    Katrin Borucki
    Kolja Schiltz
    Zoltán Sarnyai
    Hans-Gert Bernstein
    European Archives of Psychiatry and Clinical Neuroscience, 2019, 269 : 373 - 377
  • [3] Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia
    Minghuan Zhu
    Zhenjing Liu
    Yanhong Guo
    Mst. Sadia Sultana
    Kang Wu
    Xiaoe Lang
    Qinyu Lv
    Xiao Huang
    Zhenghui Yi
    Zezhi Li
    Journal of Neuroinflammation, 18
  • [4] Total antioxidant capacity, obesity and clinical correlates in first-episode and drug-naïve patients with schizophrenia
    Guan, Xiaoni
    Chen, Yuping
    Wang, Xin
    Xiu, Meihong
    Wu, Fengchun
    Zhang, Xiangyang
    SCHIZOPHRENIA RESEARCH, 2024, 264 : 81 - 86
  • [5] Plasma total antioxidant status and cognitive impairments in first-episode drug-naïve patients with schizophrenia
    Ting Xie
    Qiongwei Li
    Xingguang Luo
    Li Tian
    Zhiren Wang
    Shuping Tan
    Song Chen
    Guigang Yang
    Huimei An
    Fude Yang
    Yunlong Tan
    Cognitive Neurodynamics, 2019, 13 : 357 - 365
  • [6] Effect of serum antioxidants on cognitive dysfunction in first-episode and drug-naïve patients with major depressive disorder
    Zhang, Ziyun
    Huang, Yuanyuan
    Zhou, Sumiao
    Feng, Shixuan
    Liu, Chenyu
    Li, Hehua
    Zhang, Lida
    Han, Wei
    Wu, Fengchun
    JOURNAL OF AFFECTIVE DISORDERS, 2025, 372 : 533 - 539
  • [7] The study on agitation and structure of orbitofrontal cortex subregion in first-episode drug-naïve patients with schizophrenia
    Dong, Yingbo
    Chen, Congxin
    Li, Yuting
    Cao, Peiyu
    Tang, Yilin
    Xu, Guoxin
    Si, Qi
    Li, Runda
    Sui, Yuxiu
    BRAIN IMAGING AND BEHAVIOR, 2025, 19 (01) : 175 - 188
  • [8] Age-associated network controllability changes in first episode drug-naïve schizophrenia
    Biqiu Tang
    Wenjing Zhang
    Shikuang Deng
    Jiang Liu
    Na Hu
    Qiyong Gong
    Shi Gu
    Su Lui
    BMC Psychiatry, 22
  • [9] Higher central set point of thyroid homeostasis in drug-na?ve patients affected by first episode schizophrenia
    Zhai, Desheng
    Bing, Jialuo
    Shan, Xuchang
    Luo, Hu
    Wen, Wendy
    Gao, Songyin
    Niu, Kaijun
    Cui, Taizhen
    Li, Hongbin
    Retnakaran, Ravi
    Hao, Wei
    Zhang, Ruiling
    Zhao, Ying
    Wen, Shi Wu
    SCHIZOPHRENIA RESEARCH, 2022, 250 : 62 - 66
  • [10] Cognitive improvements linked to lysophosphatidylethanolamine after olanzapine treatment in drug-naïve first-episode schizophrenia
    Li, Juanhua
    Xu, Yuanguang
    Wang, Xin
    Liu, Caixing
    Li, Zezhi
    Xiu, Meihong
    Chen, Hongying
    METABOLOMICS, 2024, 20 (05)